Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kähler, Katharina
Pivotal, NCT02938299 / 2015-002549-72: Neoadjuvant L19IL2/L19TNF- Study	Active, not recruiting	3	214	Europe	L19IL2 + L19TNF, Surgery	Philogen S.p.A.	Malignant Melanoma	10/24	12/28
Hauschild, Axel
NCT05529316: A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma	Active, not recruiting	2	220	Europe, US, RoW	Botensilimab, AGEN1181, Balstilimab, AGEN2034	Agenus Inc.	Advanced Melanoma	05/28	05/28